Insider: Sabba Stephen L Director - LIGAND PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 32,793 | 0 | 32,793 |
| Value | $6,545,154.87 | $0.00 | $6,545,154.87 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/23/2026 | DDS | 1,000 | Direct | COM | $207.87 | $207,872.70 | 32,793 |
| 03/03/2026 | DDS | 2,034 | Direct | COM | $201.50 | $409,851.00 | 33,793 |
| 03/05/2024 | DDS | 1,893 | Direct | COM | $74.30 | $140,649.90 | 28,926 |
| 05/10/2023 | DDS | 6,408 | Direct | COM | $77.13 | $494,224.69 | 25,784 |
| 02/09/2021 | DDS | 556 | Direct | COM | $208.00 | $115,648.00 | 38,545 |
| 02/09/2021 | DDS | 14,114 | Direct | COM | $208.55 | $2,943,474.70 | 24,431 |
| 07/31/2019 | DDS | 4,091 | Direct | COM | $94.45 | $386,394.95 | 23,600 |
| 09/04/2018 | DDS | 5,000 | Direct | COM | $255.05 | $1,275,250.00 | 26,856 |
| 03/12/2018 | DDS | 622 | Direct | COM | $180.73 | $112,414.06 | 26,363 |
| 12/20/2017 | DDS | 925 | Direct | COM | $137.25 | $126,956.25 | 26,985 |
| 11/14/2011 | AAP | 1,000 | Direct | COM | $11.50 | $11,500.00 | 12,704 |
| 11/10/2011 | AAP | 1,000 | Direct | COM | $11.69 | $11,690.00 | 11,704 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research